Cisplatin-flurbiprofen prodrug, as well as preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- THE NAT CENT FOR NANOSCI & TECH NCNST OF CHINA
- Publication Date
- 2017-12-08
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medicinal chemistry and relates to a chemical prodrug and its preparation method and application. Background technique
[0002] As a representative drug in the field of inorganic medicinal chemistry, cisplatin has been used in the clinical trials of various solid tumors such as ovarian cancer, testicular cancer, bladder cancer, and lung cancer since it was approved for use by the US Food and Drug Administration (FDA) in 1978. First-line chemotherapy is one of the most widely used broad-spectrum anticancer drugs in clinical practice. Its mechanism of action is: after cisplatin enters the cell and is activated, it binds to DNA in the nucleus to form an adduct, inhibits the transcription and replication of DNA, and induces apoptosis. Cisplatin is effective, but its disadvantages are also obvious, such as dose-limiting toxicity (ototoxicity, nephrotoxicity, neurotoxicity, bone marrow suppression, etc.), severe gastroi...